Tony Kim holds up microfluidic chips with Yom and Sei

*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************

Tony Kim holds up microfluidic chips with Yom and Sei

Principal investigator Tony Kim with graduate research assistant Yoshitaka Sei (r.) and research engineer Jiwon Yom (m.) in Kim's lab at Georgia Tech. They are holding microvessel mimicking chips. More advanced versions to be developed in their new NIH-funded project will contain artificial human coronary arteries for research to better understand HDL, or good cholesterol, and why experimental treatments using it to fight atherosclerosis have failed. They hope to optimize HDL cocktails to be effective against the deadly condition that is the foremost cause of coronary artery disease and stroke. Credit: Georgia Tech / Christopher Moore

Additional Information

Groups

News Room, Research Horizons

Categories
Research, Biotechnology, Health, Bioengineering, Genetics, Life Sciences and Biology, Nanotechnology and Nanoscience
Keywords
atheroscleroisis, atherosclerosis treatment, HDL, Hdl Cholesterol, HDL-C, Good Cholesterol, CAD, Kidney Ailment, Peripheral Artery Disease, peripheral atherosclerosis, Cardiac Arrest, Clogged Arteries, Hardening Of The Arteries, Stroke, Carotid Artery Disease, carotid artery plaque, Plaque Build Up
Status
  • Created By: Ben Brumfield
  • Workflow Status: Published
  • Created On: Oct 4, 2017 - 5:08pm
  • Last Updated: Oct 5, 2017 - 12:17pm